Shattuck Labs Valuation Multiples

Shattuck Labs Overview

About Shattuck Labs

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Founded

2016

HQ

Employees

44

Website

shattucklabs.com

Sectors

BiopharmaceuticalsBioTech

Financials (LTM)

Revenue: $726K

EBITDA: ($52M)

EV

$484M

Valuation Multiples

Multiples.vc

Start free trial

Shattuck Labs Financials

Shattuck Labs reported last 12-month revenue of $726K and negative EBITDA of ($52M).

In the same LTM period, Shattuck Labs generated $726K in gross profit, ($52M) in EBITDA losses, and had net loss of ($51M).

Shattuck Labs P&L

In the most recent fiscal year, Shattuck Labs reported revenue of $1M and EBITDA of ($48M).

Shattuck Labs expects next 12-month revenue of XXX and NTM EBITDA of XXX

Shattuck Labs Stock Performance

Shattuck Labs has current market cap of $560M, and enterprise value of $484M.

Shattuck Labs' stock price is $7.41.

Shattuck Labs Valuation Multiples

Shattuck Labs trades at 666.7x EV/Revenue multiple, and (9.3x) EV/EBITDA.

Shattuck Labs Financial Valuation Multiples

As of April 11, 2026, Shattuck Labs has market cap of $560M and EV of $484M.

Equity research analysts estimate Shattuck Labs' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Shattuck Labs has a P/E ratio of (10.9x).

Shattuck Labs Margins & Growth Rates

Shattuck Labs' revenue in the last 12 month declined by (100%).

Shattuck Labs' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.2M for the same period.

Shattuck Labs Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Shattuck Labs M&A Activity

Shattuck Labs acquired XXX companies to date.

Last acquisition by Shattuck Labs was on XXXXXXXX, XXXXX. Shattuck Labs acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Shattuck Labs Investment Activity

Shattuck Labs invested in XXX companies to date.

Shattuck Labs made its latest investment on XXXXXXXX, XXXXX. Shattuck Labs invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).